Could ditching Beta-Blockers boost quality of life for seniors with heart failure?

NCT ID NCT07298993

First seen Jun 24, 2026 · Last updated Jul 16, 2026 · Updated 3 times

Summary

This study looks at whether gradually stopping beta-blockers (medicines often used for heart failure) can improve symptoms and daily function in adults aged 60 and older with a specific type of heart failure called HFpEF. About 240 participants will either taper off their beta-blocker or continue it, and researchers will track hospitalizations, quality of life, and mood over 4 months. The goal is to see if removing these medications, when they may no longer be needed, leads to better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
beta-blockers (atenolol, bisoprolol, carvedilol, metoprolol succinate, metoprolol tartrate)
What this could lead to
If successful, this could show that stopping unnecessary beta-blockers helps older adults with HFpEF feel better and have fewer hospitalizations.
What could go wrong
This is a small, early-phase study (240 participants) focused on symptom improvement, not a cure. Results may not apply to all patients, and stopping beta-blockers could carry risks like increased heart rate or blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kaiser Permanente Northern California (KPNC)

    Pleasanton, California, 94588, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.